Floatz logo

5-azacytidine

Anatomic Stage III Breast Cancer AJCC v8

City of Hope Medical CenterPhase 2Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
89/ 100

Competitive context

22 Active assets in the Anatomic Stage III Breast Cancer AJCC v8 cohort.

Asset / SponsorPhaseRating
PANITUMUMAB
National Cancer Institute (NCI)
Phase 2BB
Nilotinib
National Cancer Institute (NCI)
Phase 2BB
Gdc-0449
OHSU Knight Cancer Institute
Phase 2B
Perflutren Lipid Microsphere Intravenous Suspension
UNC Lineberger Comprehensive Cancer Center
Phase 2/3B
Ceralasertib
National Cancer Institute (NCI)
Phase 2B

View all 27 →

Same molecule, other indications

5-azacytidine is also rated in:

Recurrent Non-Hodgkin LymphomaDormant
BB
Indicative ·
70 / 100
View asset →
Acute Myeloid Leukaemia; Myelodysplastic Syndromes;Chronic Myelomonocytic LeukemiaDormant
BB
Indicative ·
65 / 100
View asset →
myelodysplastic syndromeDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →